'I trust you': How a Lancaster family helped lay the building blocks for gene-therapy breakthroughs at Nationwide Children ’s

Andrew is the “And” in Andelyn Biosciences. He was 3 in 2001 when he was diagnosed with Duchenne muscular dystrophy, the most common and among the most aggressive forms of the inherited condition. Patients usually don’t reach 20.

Source: bizjournals.com Health Care:Biotechnology headlines - January 30, 2020 Category: Biotechnology Authors: Carrie Ghose Source Type: news